Growing concerns in the outbreak of measles in France and Switzerland as well as across the world as in 2025, the highest number of measles cases in over 25 years has been recorded[1]. This surge has raised alarms among health authorities and has been attributed to a decrease in vaccinations due to the Covid-19 pandemic[2].

The measles virus is very contagious and can be particularly dangerous for children and vulnerable adults. It is recommended that in order to prevent the circulation of the disease, at least 95% of the population must be immunised[3], however, many countries are struggling to achieve the 95% vaccination rate necessary to maintain herd immunity[4].

The World Health Organization (WHO) and UNICEF have called for urgent action to address these gaps, highlighting the importance of vaccination as the best defense against the disease[5].

As measles cases continue to rise, the situation serves as a stark reminder of the critical need for high vaccination coverage to protect public health and prevent the resurgence of preventable diseases.

We remind Members of the CHIS the importance of vaccination and that vaccinations prescribed and administered by a doctor are reimbursed according to the General Rule. Under the CHIS Regulations, the conditions in force in the country where the vaccination is dispensed apply to the UNIQA reimbursements.